2024-511254-51-00RecruitingPhase 1
Safety and Tolerability of a Timolol Releasing Intraocular Implant in Subjects With Primary Open-angle Glaucoma
Trial Snapshot
- Phase
- Phase 1
- Status
- Recruiting
- Sponsor
- Eyed Pharma
- Enrollment
- 18
- Locations
- 6
Study Overview
Brief Summary
No summary available.
Eligibility Criteria
- Ages
- 18 years to 65+ years (65+ Years, 18-64 Years)
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
Regulatory
Scientific
Eyed Pharma
Study Sites (6)
Loading locations...
Similar Trials
Recruiting
Phase 1
Safety, Tolerability and Symptomatic Efficacy of the ROCK-Inhibitor Fasudil in Patients with Parkinson's Disease(ROCK-PD)Idiopathic Parkinson´s DiseaseMedDRA version: 20.0Level: PTClassification code 10061536Term: Parkinson's diseaseSystem Organ Class: 10029205 - Nervous system disordersEUCTR2021-003879-34-DEKlinikum rechts der Isar der Technischen Universität München75
Completed
Phase 1
Evaluation of the Safety and Tolerability of the ‘LeVe CPAP Flow Generator’ in Healthy Volunteers at Mengo Hospital in Kampala UgandaRespiratoryPACTR202105734146484Mengo Hospital20
Completed
Not Applicable
Evaluation of the safety and tolerability of the primary posterior capsulotomy during femtosecond laser-assisted cataract surgeryH26.9H26.4Cataract, unspecifiedAfter-cataractDRKS00010845niversitätsklinikum Knappschaftskrankenhaus Bochum GmbH Augenklinik41
Completed
Phase 1
Evaluation of the safety and feasibility of intra ovarian injection of menstrual blood derived stem cells (MenSCs) in women with poor ovarian response.IRCT20180619040147N2Iranian Academic Center for Education Culture and Research36
Withdrawn
Phase 1
Safety and tolerability of the Traditional Chinese Medicine Formulation GOPAC in patients with advanced malignancyAdvanced malignancy (palliative)Cancer - Other cancer typesACTRN12609000652279Sydney South West Area Health Service70